Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Stock Price, News & Analysis

Longboard Pharmaceuticals logo

About Longboard Pharmaceuticals Stock (NASDAQ:LBPH)

Advanced Chart

Key Stats

Today's Range
$59.98
$59.98
50-Day Range
$59.50
$59.98
52-Week Range
$27.35
$60.03
Volume
N/A
Average Volume
1.37 million shs
Market Capitalization
$2.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.43
Consensus Rating
Hold

Company Overview

Receive LBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LBPH Stock News Headlines

H Lundbeck A/S (HLUNAC.XD)
H. Lundbeck A/S (HLUN-A.CO)
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

LBPH Stock Analysis - Frequently Asked Questions

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) released its earnings results on Thursday, August, 1st. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.46) by $0.10.
Read the conference call transcript
.

Longboard Pharmaceuticals (LBPH) raised $75 million in an IPO on Friday, March 12th 2021. The company issued 5,000,000 shares at $14.00-$16.00 per share. Citigroup, Evercore ISI, Guggenheim Securities and Cantor acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Longboard Pharmaceuticals investors own include JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
8/01/2024
Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LBPH
CIK
1832168
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$90.00
Low Price Target
$44.00
Potential Upside/Downside
+5.7%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.03%
Return on Assets
-30.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.97
Quick Ratio
15.97

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
35.92

Miscellaneous

Outstanding Shares
39,050,000
Free Float
37,234,000
Market Cap
$2.34 billion
Optionable
Optionable
Beta
1.00
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:LBPH) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners